Skip to content

← All news

Markets

Guggenheim cuts Tenax Therapeutics price target to $4 on trial miss

1 source ·2 articles ·Aug 13, 11:34 UTC Tenax Therapeutics

Covered by 1 outlet

All coverage · 2 articles

Investing.com UK ·Aug 13, 11:34 UTC

Guggenheim cuts Cava stock price target on margin pressures

Investing.com News ·Aug 11, 11:46 UTC

Guggenheim cuts Tenax Therapeutics price target to $4 on trial miss